Serevent

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1997

Specific Treatments:

asthma

Find Related Trials for The Following Conditions

General Information

The U.S. Food and Drug Administration (FDA) approved Serevent for the maintenance treatment of asthma and in the prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease. This includes patients with symptoms of nocturnal asthma, who require regular treatment with inhaled, short-acting beta2-agonists.